Individual frailty phenotype components and mortality in adults with type 2 diabetes: A UK Biobank study

Diabetes Res Clin Pract. 2023 Jan:195:110155. doi: 10.1016/j.diabres.2022.110155. Epub 2022 Nov 24.

Abstract

Aims: This study aimed to explore associations between frailty components and mortality and rank prognostic relevance of each frailty component in predicting mortality in adults with and without type 2 diabetes (T2D).

Methods: We used data from the UK Biobank. Associations and prognostic discrimination of individual Fried's frailty components and the overall frailty status with all-cause and cardiovascular (CVD) mortality were investigated using Cox proportional-hazard models and C-index in adults with and without T2D.

Results: In both populations the strongest association with all-cause mortality across all frailty components and overall frailty status was observed for slow walking pace (without T2D Hazard Ratio [HR] 2.25, 95 %CI: 2.12-2.38 and with T2D HR 1.95, 95 %CI: 1.67-2.28). Similarly, slow walking pace was associated with a greater risk of CVD mortality. The combination of T2D and slow walking pace had the strongest association with all-cause and CVD mortality, compared to the combination of T2D and other frailty components or overall frailty status. Slow walking pace also provided the greatest prognostic discrimination.

Conclusion: Slow walking pace has a stronger predictive factor for all-cause and CVD mortality compared to other frailty components and overall frailty status, especially when simultaneously present with T2D.

Keywords: Physical function; Prognostic relevance; Walking-pace.

MeSH terms

  • Biological Specimen Banks
  • Cardiovascular Diseases*
  • Diabetes Mellitus, Type 2*
  • Frailty*
  • Humans
  • Phenotype
  • Risk Factors
  • United Kingdom / epidemiology